Emergency Investigational New Drug (EIND) Applications for Antiviral Products | |||
---|---|---|---|
분류 | Investigational New drug application | 조회 | 2409 |
발행년도 | 2014 | 등록일 | 2015-07-27 |
출처 | FDA (바로가기) | ||
The following information is to be used by physicians who would like to request an Emergency IND for an antiviral product regulated by the Center for Drug Evaluation and Research (CDER)/Division of Antiviral Products (DAVP). Emergency IND requests for products not regulated by CDER/DAVP should be directed to the appropriate point of contact for the FDA Center/Division in which the product is reviewed.
|
|
이전글 | CDER New Drug Review |
---|---|
다음글 | Guidance Investigational New Drug Application for Positron Emission Tomography (PET) Drugs |